The 2013 Doctors 2.0 & You conference is being held in the Cité Universitaire, Paris, from 6th – 7th June 2013. Nitro’s own: Andy Stafford, Peter Mortimer, Rachel Mills, and Jules Pancholi; are at the event along with Boehringer Ingleheim’s John Pugh.
On June 13th – 14th the latest digital health innovations will be shared at the Digital Health Summer Summit 2013. The healthcare industry’s most forward thinkers and doers will be attending and presenting; preparing to face proposed solutions to some of the most pressing issues in healthcare today.
Attending the conference will be: executives from healthcare device and technology companies; CE executives looking to expand into digital health and fitness; entrepreneurs, inventors and healthcare and wellness innovation pioneers; healthcare professionals including physicians, nurses and hospital administrators; insurance companies and payers; healthcare, technology, business and lifestyle press or analysts; digital health marketers, developers, and designers; VCs, angels, private investors and other vested financial players; academics, recent graduates and students in medicine or healthcare technology and business; anyone else interested in the combination of health, technology, and business.
A new pill has been developed by Proteus Digital Health which sends an SMS alert to a designated mobile phone once the patient has ingested it. The technology behind this is already available over-the-counter in the UK and can help care-givers manage whether their patient is taking their medication, without having to physically be there every time.
A small sensor is included within the patient’s medication, which is no bigger than a grain of sand. The sensor is made from copper and magnesium, two metals which are fully digestible, generate power when in contact with moisture, and already commonly found in the human diet and supplements.
During 2013 challenges within medical innovation includes: proactive or reactive treatments; innovation; risk assessment when treating; and cost of drug development. As the below infographic explains:
Trials are due to begin to test an intelligent microchip designed to suppress appetite. In a bid to tackle obesity, the chip is attached to the vagus nerve, which regulates the numerous bodily functions, including: breathing rate; heart rate; digestive acid secretion; gut contraction; and provides signals to the brain on how these functions are operating.